Memorandum

ViaCyte announces second clinical trial site at University of Alberta - July 30, 2015

Yesterday, ViaCyte announced its second clinical trial site at University of Alberta. This follows UCSD and the trial has a n=40 and is slated to wrap up in August 2017 according to ClinicalTrials.gov (Identifier: NCT02239354).